Ahmed Abd El-Rahman El-Ashmawy (Ahmed A El-Ashmawy)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 6

Top Topics

Benign Prostatic Hyperplasia

Top Venues

Scientific reports

AAPS PharmSciTech

Advanced pharmaceutical bulletin

Drug development and industrial pharmacy

This page only lists publications with an associated author ORCID identifier.

Publications

Sanagik Sabry Abu El Wafa, Ahmed Abd El-Rahman El-Ashmawy, Hanaa A H Kassem, Ibrahim H Eissa, Mohammed Abu-Elghait, Nermin A Younis, Inas Youssef Younis
Optimization of oil yield of Pelargonium graveolens L'Hér using Box-Behnken design in relation to its antimicrobial activity and in silico study. Scientific reports 13 (1) (2023)
Noha Mokhtar Abd-El-Aziz, Mohamed S Hifnawy, Ahmed Abd El-Rahman El-Ashmawy, Rehab A Lotfy, Inas Youssef Younis
Application of Box-Behnken design for optimization of phenolics extraction from Leontodon hispidulus in relation to its antioxidant, anti-inflammatory and cytotoxic activities. Scientific reports 12 (1) (2022)
Ahmed Abd El-Rahman El-Ashmawy, Aya R Abdou, Nesrin F Taha, Ebtesam W Elsayed, Khaled M Mahmoud, Laila H Emara
Formulation, Pharmacokinetics evaluation, and IVIVC Assessment of Gliclazide Multiparticulates in Rat Model. AAPS PharmSciTech 22 (4) (2021)
Asmaa Nabil Elboraey, Hanan Hassan Abo-Almaged, Ahmed Abd El-Rahman El-Ashmawy, Aya Rashad Abdou, Amani Ramadan Moussa, Laila Hassanian Emara, Hossam Mohammed El-Masry, Gehan El-Tabie El Bassyouni, Magda Ismail Ramzy
Biological and Mechanical Properties of Denture Base Material as a Vehicle for Novel Hydroxyapatite Nanoparticles Loaded with Drug. Advanced pharmaceutical bulletin 11 (1) (2020)
Ebtesam W Elsayed, Ahmed Abd El-Rahman El-Ashmawy, Nadia M Mursi, Laila Hassanian Emara
Optimization of gliclazide loaded alginate-gelatin beads employing central composite design. Drug development and industrial pharmacy 45 (12) (2019)
Laila Hassanian Emara, Ahmed Abd El-Rahman El-Ashmawy, Nesrin F Taha
Stability and bioavailability of diltiazem/polyethylene oxide matrix tablets. Pharmaceutical development and technology 23 (10) (2017)